BlackRock Investment Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

BlackRock Investment Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$382K	Buy	77,761 +642	+0.8%	+$3.29K	﹤0.01%	3116
2016 Q3	$383K	Buy	77,119 +1,159	+2%	+$5.93K	﹤0.01%	3130
2016 Q2	$387K	Buy	75,960 +7,159	+10%	+$38.5K	﹤0.01%	3172
2016 Q1	$393K	Buy	68,801 +1,079	+2%	+$7.54K	﹤0.01%	2986
2015 Q4	$703K	Buy	67,722 +293	+0.4%	+$3.98K	﹤0.01%	2826
2015 Q3	$1.25M	Sell	67,429 -2,018	-3%	-$38.9K	﹤0.01%	2437
2015 Q2	$1.35M	Buy	69,447 +13,305	+24%	+$235K	﹤0.01%	2548
2015 Q1	$987K	Buy	56,142 +148	+0.3%	+$2.49K	﹤0.01%	2528
2014 Q4	$895K	Sell	55,994 -123	-0.2%	-$1.65K	﹤0.01%	2616
2014 Q3	$707K	Buy	56,117 +1,513	+3%	+$21.6K	﹤0.01%	2759
2014 Q2	$853K	Buy	54,604 +8,860	+19%	+$130K	﹤0.01%	2717
2014 Q1	$601K	Sell	45,744 -9	-0%	-$141	﹤0.01%	2852
2013 Q4	$736K	Sell	45,753 -1,094	-2%	-$17.4K	﹤0.01%	2722
2013 Q3	$780K	Buy	46,847 +2,058	+5%	+$30.4K	﹤0.01%	2621
2013 Q2	$451K	Buy	+44,789	New	+$471K	﹤0.01%	2904

Other funds holding OSIR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Investment Management's OSIR Position: Q4 2016 in Review

BlackRock Investment Management increased its Osiris Therapeutics, Inc. Common Stock (OSIR) stake by 0.83% in Q4 2016, buying an estimated $3.29K and bringing the position to 77,761 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #3116.

BlackRock Investment Management first reported a position in OSIR in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.35M in Q2 2015. 64 funds tracked by Wall St. Rank hold OSIR as of Q4 2016.

BlackRock Investment Management held 77,761 shares of Osiris Therapeutics, Inc. Common Stock worth $382K as of Q4 2016.
BlackRock Investment Management bought 642 Osiris Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $3.29K.
Osiris Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3116 holding.
BlackRock Investment Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Osiris Therapeutics, Inc. Common Stock position peaked at $1.35M in Q2 2015.
64 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.